Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydroformylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102093432A details a high-yield rhodium catalyst synthesis. This report analyzes cost reduction and supply chain reliability for chemical manufacturing.
Patent CN1264808C details a novel 3-pentenenitrile route to alkyl 6-aminocaproate, eliminating hexamethylenediamine byproducts and enabling high-purity caprolactam production.
Novel biomass-derived route for polyamide intermediates. Reduces energy and waste via catalytic hydroformylation and carbonylation technology.
Novel synthesis of O-SPINOL ligands enables significant cost reduction in fine chemical manufacturing with high purity and scalability for global supply chains.
Novel phosphoramidite ligand enables high-yield hydroformylation for BDO intermediates with enhanced catalyst stability and recycling capabilities.
Patent CN115739184B reveals a novel Rhodium catalyst for diisobutylene hydroformylation, offering high selectivity and supply chain stability for plasticizer intermediates.
Patent CN115124572A reveals a novel tetradentate phosphine ligand enabling high-selectivity linear dialdehyde production with superior catalyst stability and reduced metal leaching.
Patent CN113004326B discloses advanced bidentate phosphine ligands enhancing adipaldehyde selectivity up to 60%, offering a viable route for nylon precursors.
Patent CN102746338B reveals novel spiroketal ligands enabling high-selectivity hydroformylation. Discover cost-effective catalytic solutions for fine chemical manufacturing.
Patent CN119874773B reveals advanced ligand enhancing conversion stability. Delivers supply chain reliability and cost optimization for global chemical manufacturing.
Patent CN112679336A reveals a green heterogeneous Pd@POL catalytic route for phenylpropionic acids, offering reduced heavy metal residues and enhanced supply chain reliability for pharmaceutical intermediates.